83 related articles for article (PubMed ID: 24144101)
1. The high prevalence of metabolic syndrome in polymyositis.
de Souza FH; Shinjo SK
Clin Exp Rheumatol; 2014; 32(1):82-7. PubMed ID: 24144101
[TBL] [Abstract][Full Text] [Related]
2. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP
Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity.
da Cunha VR; Brenol CV; Brenol JC; Fuchs SC; Arlindo EM; Melo IM; Machado CA; de Castro Chaves H; Xavier RM
Scand J Rheumatol; 2012 May; 41(3):186-91. PubMed ID: 22416768
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
[TBL] [Abstract][Full Text] [Related]
5. Noncardiogenic stroke patients with metabolic syndrome have more border-zone infarction and intracranial artery stenosis.
Zhang Z; Xiao M; Ye Z; Zhang W; Han B; Li Y
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):629-34. PubMed ID: 25561314
[TBL] [Abstract][Full Text] [Related]
6. Prognostic interactions between cardiovascular risk factors.
Vishram JK
Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activity.
Papadakis JA; Sidiropoulos PI; Karvounaris SA; Vrentzos GE; Spanakis EK; Ganotakis ES; Kritikos HD; Mikhailidis DP; Boumpas DT
Clin Exp Rheumatol; 2009; 27(2):292-8. PubMed ID: 19473571
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus.
Mok CC; Poon WL; Lai JP; Wong CK; Chiu SM; Wong CK; Lun SW; Ko GT; Lam CW; Lam CS
Scand J Rheumatol; 2010; 39(1):42-9. PubMed ID: 20132070
[TBL] [Abstract][Full Text] [Related]
9. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
Sirdah MM; Abu Ghali AS; Al Laham NA
Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age.
Medeiros MM; Xavier de Oliveira ÍM; Ribeiro ÁT
Rheumatol Int; 2016 Jan; 36(1):117-24. PubMed ID: 26149124
[TBL] [Abstract][Full Text] [Related]
11. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.
Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F;
Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.
Athyros VG; Bouloukos VI; Pehlivanidis AN; Papageorgiou AA; Dionysopoulou SG; Symeonidis AN; Petridis DI; Kapousouzi MI; Satsoglou EA; Mikhailidis DP;
Diabetes Obes Metab; 2005 Jul; 7(4):397-405. PubMed ID: 15955126
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study.
Karvounaris SA; Sidiropoulos PI; Papadakis JA; Spanakis EK; Bertsias GK; Kritikos HD; Ganotakis ES; Boumpas DT
Ann Rheum Dis; 2007 Jan; 66(1):28-33. PubMed ID: 16793841
[TBL] [Abstract][Full Text] [Related]
14. Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease.
de Moraes MT; de Souza FH; de Barros TB; Shinjo SK
Arthritis Care Res (Hoboken); 2013 May; 65(5):793-9. PubMed ID: 23139205
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data.
Puenpatom RA; Victor TW
Postgrad Med; 2009 Nov; 121(6):9-20. PubMed ID: 19940413
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
[TBL] [Abstract][Full Text] [Related]
17. A two fold risk of metabolic syndrome in a sample of patients with schizophrenia: do consanguinity and family history increase risk?
Bener A; Al-Hamaq AO; Dafeeah EE
Diabetes Metab Syndr; 2014; 8(1):24-9. PubMed ID: 24661754
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
Song SH; Hardisty CA
QJM; 2008 Jun; 101(6):487-91. PubMed ID: 18353792
[TBL] [Abstract][Full Text] [Related]
19. Serum hyaluronic acid in polymyositis: high serum levels tend to correlate with disease activity.
Silva MB; Silva MG; Shinjo SK
Acta Reumatol Port; 2014; 39(3):248-53. PubMed ID: 25326405
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of clinical and laboratory manifestations and comorbidities in polymyositis according to gender.
Souza FH; Levy-Neto M; Shinjo SK
Rev Bras Reumatol; 2011; 51(5):428-83. PubMed ID: 21952995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
